Table 1.

UBE2L3 rs5754217 genotype and allele frequencies in controls and cases stratified by anti-La autoantibody status.

Background	Clinical Category	N	GG	GT	TT	MAF (T)	La+ Cases vs LA− Cases, Additive	La+ Cases vs LA− Cases, Recessive	La+ Cases vs Controls, Additive	La+ Cases vs Controls, Recessive
African American	Controls	239	74	127	38	0.425	OR 1.57, p = 0.050	OR 2.21, p = 0.027	OR 1.69, p = 0.022	OR 2.55, p = 0.0061
	Cases	252	71	129	52	0.462
	La+ Cases	46	10	21	15	0.554
	La− Cases	206	61	108	37	0.442
European American	Controls	105	64	36	5	0.219	OR 1.32, p = 0.47	OR 3.52, p = 0.27	OR 1.31, p = 0.46	OR 1.66, p = 0.38
	Cases	143	88	51	4	0.206
	La+ Cases	13	7	5	1	0.269
	La− Cases	130	81	46	3	0.200

La+ indicates patients with a positive test for anti-La antibodies. La− indicates patients who lack anti-La antibodies. MAF: minor allele frequency.